Angiotensin-converting enzyme polymorphism and completed suicide: An association in caucasians and evidence for a link with a method of self-injury

Neuropsychobiology

Volumn 59, Issue 3, 2009, Pages 151-158

  Fudalej, Sylwia ^a   Fudalej, Marcin ^a   Kostrzewa, Grayna ^a   Kuźniar, Piotr ^a   Franaszczyk, Maria ^a   Wojnar, Marcin ^a   Krajewski, Paweł ^a   Płoski, Rafał ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiotensin converting enzyme; Genetics; Males; Suicide, method

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DEGRADATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUICIDE;

ADULT; AGING; ALLELES; DEPRESSION; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PREVALENCE; SEX CHARACTERISTICS; SUICIDE;

EID: 65549096912     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218077     Document Type: Article

References (29)

1. Brent DA, Mann JJ: Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005; 133:13-24.
2. Baldessarini RJ, Hennen J: Genetics of suicide: an overview. Harv Rev Psychiatry 2004; 12:1-13.
3. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4:819-828.
4. Statham DJ, Heath AC, Madden PAF, Bucholz KK, Bierut L, Dinwiddie SH, Slutske WS, Dunne MP, Martin NG: Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998; 28:839-855.
5. Hishimoto A, Shirakawa O, Nishiguchi N, Hashimoto T, Yanagi M, Nushida H, Ueno Y, Maeda K: Association between a functional polymorphism in the renin-angiotensin system and completed suicide. J Neural Transm 2006; 113:1915-1920.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
7. Visvikis-Siest S, Marteau JB: Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006; 17:139-151.
8. Gard PR: The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 2002; 438:1-14.
9. Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ: Angiotensin regulates release and synthesis of serotonin in brain. Science 1978; 202:1091-1093.
10. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatr y 2005; 57: 336-342.
11. Arinami T, Li L, Mitsushio H, Itokawa M, Hamaguchi H, Toru M: An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatr y 1996; 40: 1122-1127.
12. Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R , Holm G, Andersch S, Allgulander C, Eriksson E: Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet 2004; 127B:81-84.
13. Mueller-Malesinska M, Nowak M, Ploski R, WaligoraJ, Korniszewski L: Epidemiology of 35delG mutation in GJB2 gene in a Polish population. J Audiol Med 2001; 10:136-141.
14. Odawara M, Matsunuma A, Yamashita K: Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance. Hum Genet 1997; 100:163-166.
15. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, Wiley Interscience, 2000.
16. Miettinen O, Nurminen M: Comparative analysis of two rates. Stat Med 1985; 4:213- 226.
17. Sparks DL, Hunsaker JC III, Amouyel P, Malafosse A, Bellivier F, Leboyer M, Courtet P, Helbecque N: Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:290-294.
18. Zubenko GS, Nixon RA: Mood-elevating effect of captopril in depressed patients. Am J Psychiatr y 1984; 14 1: 110 -111 .
19. Vuckovic A, Cohen BM, Zubenko GS: The use of captopril in treatment-resistant depression: an open trial. J Clin Psychophar-macol 1991; 11:395-396.
20. Baghai TC, Binder EB, Schule C, Salyakina D, Eser D, Lucae S, Zwanzger P, Haberger C, Zill P, Ising M, Deiml T, Uhr M, Illig T, Wichmann HE, Modell S, Nothdurfter C, Holsboer F, Muller-Myhsok B, Moller HJ, Rupprecht R, Bondy B: Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 2006; 11:1003-1015.
21. Saab YB, Gard PR, Yeoman MS, Mfarrej B, El Moalem H, Ingram MJ: Renin-angiotensin-system gene polymorphisms and depression. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1113 -1118.
22. Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P: Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a gender-specific effect? World J Biol Psychiatry 2007, pp 1-5.
23. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC: ACE gene typing. Lancet 1994; 343:851.
24. Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3:120-121.
25. Sarkar P, Nicholson G, Hall G: Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anesth 2006; 53:994-1003.
26. Bertrand ME: Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin 2004; 20: 1559-1569.
27. Callreus T, Agerskov AU, Hallas J, Andersen M: Cardiovascular drugs and the risk of suicide: a nested case-control study. Eur J Clin Pharmacol 2007; 63:591-596.
28. Sorensen HT, Mellemkjaer L, Olsen JH: Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 2001; 52:313-318.
29. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCM: ACE polymorphisms. Circ Res 2006; 98:1123-1133.